Medicines for Europe represents the pharmaceutical companies supplying the largest share of medicines across Europe and is the voice of the generic, biosimilar and value added industries. Medicines for Europe members’ portfolio cover 80% of therapy areas, and in so doing, safeguards the sustainability of Europe’s healthcare systems for future generations.

Member Companies-Full Members

Restrictions on Appointees Leaving Government

The Biden Executive Order imposes three “revolving door” bans on appointees who leave the federal government:

Le Dictionnaire Explicatif du Lobbying DE FOULOY est un ouvrage de référence mis à jour sur l'art du lobbying et de la défense d'intérêts et représente une version élargie du Guide de réference du lobbyiste professionnel publié à l'origine sous le titre anglais 'The Professional Lobbyist's Desk Reference' ainsi que la deuxième édition du 'Fouloy's Explanatory Lobbying Dictionary'. 

Commercial agreements typically specify specific standards in describing the degree of effort that a party is expected to undertake in order to carry out certain contractual obligations. For example, in many contracts, reference is made to one or the other party to the contract undertaking its "best efforts," "reasonable efforts" or "commercially reasonable efforts." Often, much time and attention is devoted to negotiating which of these standards will apply. Nevertheless, ambiguities remain as to the precise meaning of each of such standards.

What is proposed hereunder is the creation of a web-based system called ‘CHARLEMAGNE ’ that would be a forum for lobbyists, constituents, and other interested parties to come together to publicly and transparently debate legislation, and in the process provide EU staff, journalists, and the public access to the best available arguments, information, and ideas about public policy – all in a way that is easily searchable and sortable. In order to make CHARLEMAGNE easily navigable, different types of participants should use the system in different ways.

EuropaBio represents 45 corporate and associate members, and 19 national  associations and Bioregions

Corporate Members

President Biden’s climate plan is ambitious, but achievable, many experts believe. On April 22, Earth Day, Biden announced a national goal of cutting greenhouse gas emissions by up to 52% by 2030, compared with 2005 levels.

Biden has also set goals of eliminating greenhouse gas emissions in the power sector by 2035 and in the overall economy by 2050. Princeton University’s Andlinger Center for Energy and the Environment describes five different scenarios for reaching these goals

Scenario 1: High Electrification

The EU had 224,538 public charging points in 2020. 76% of all charging points are located in 4 countries (Netherlands, Germany, France, and UK). The four top selling EV markets in the EU represent 76% of public charging infrastructure but also concentrate 75% of the EVs, showing that both EV rollout and infrastructure deployment is happening in parallel. Since these countries represent such a large share of EU’s GDP and car sales, it is natural for these countries to be the starting point of new technology adoption.

Past revolving-door scandals have over the years inspired pledges for more institutional accountability. Current rules require recent Commissioners to seek approval from the European Commission for new roles.